Cancer chronotherapy: timing drug administration to optimise efficacy and reduce toxicity Oncologist Francis Lévi has been probing the potential of chronotherapy for 20 years, but momentum is now building as more researchers join his mission to prove that the time cancer drugs are given influences their efficacy and toxicity.…
FDA approves uridine triacetate as chemotherapy overdose rescue A new rescue treatment for patients accidentally given an overdose of chemotherapy has been approved by the US Food and Drug Administration.…
FDA approves ‘cooling cap’ to reduce hair loss during chemotherapy A cap that cools the scalp to reduce hair loss (alopecia) in women undergoing chemotherapy for breast cancer has been cleared for marketing by the US Food and Drug Administration.…
Helminth infections: diagnosis and treatment Diagnosis and selection of appropriate drug treatments for common helminth infections.…
Antibiotic resistance threatens surgical procedures and chemotherapy, study warns Around 120,000 additional infections and 6,300 deaths in the United States each year could occur as a result of a 30% reduction in the efficacy of prophylactic use of antibiotics.…
Breast cancer drug tamoxifen shows antimicrobial activity Tamoxifen, used for prevention and treatment of breast cancer, has been shown to enhance the antibacterial activity of white blood cells in a study published in Nature Communications.…
Pregnant women can receive chemotherapy without harm to foetus, study suggests Pregnant women who have cancer do not necessarily need to have a termination for fear of the harm their treatment will cause a developing baby, study finds. …
A career in chemotherapy and nutrition Independent prescriber Priya Mistry (pictured) has been working as the lead pharmacist in nutrition and peritoneal malignancy at Basingstoke and North Hampshire Hospital for 12 years When working in the complicated areas of parenteral nutrition and chemotherapy, the best advice is to ke…
FDA approves rolapitant to prevent chemotherapy-induced nausea The US Food and Drug Administration has approved rolapitant as part of a combination of drugs to prevent nausea and vomiting caused by certain types of cancer chemotherapy.…
Palliative chemotherapy may harm patient’s quality of life Chemotherapy for end-stage cancer does not improve, and may harm, a patient’s quality of life in their final week of life, report researchers.…
